Gene · 3363
Papers1,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serotonin receptors in epilepsy: Novel treatment targets? | Epilepsia Open | 2022 | 35075810 | PubTator, text mining | PubMed |
| Novel Molecular Targets of Antidepressants. | Molecules | 2022 | 35056845 | PubTator, text mining | PubMed |
| Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma. | Cells | 2022 | 35053377 | PubTator, text mining | PubMed |
| Which first-generation antipsychotics should be "repurposed" for the treatment of schizophrenia. | Eur Arch Psychiatry Clin Neurosci | 2022 | 35038002 | PubTator, text mining | PubMed |
| Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports. | Drug Saf | 2022 | 35020178 | PubTator, text mining | PubMed |
| Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders. | Transl Psychiatry | 2022 | 35013130 | PubTator, text mining | PubMed |
| Hydroxy Pentacyclic Triterpene Acid, Kaempferol, Inhibits the Human 5-Hydroxytryptamine Type 3A Receptor Activity. | Int J Mol Sci | 2022 | 35008969 | PubTator, text mining | PubMed |
| Regular Aerobic Exercise Attenuates Pain and Anxiety in Mice by Restoring Serotonin-Modulated Synaptic Plasticity in the Anterior Cingulate Cortex. | Med Sci Sports Exerc | 2022 | 34935710 | PubTator, text mining | PubMed |
| β-Catenin activation and illicit receptor expression in adrenocortical cells. | Endocr Relat Cancer | 2022 | 34935630 | PubTator, text mining | PubMed |
| Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes. | Drugs Aging | 2022 | 34882284 | PubTator, text mining | PubMed |
| Antipsychotics increase steroidogenic enzyme gene expression in the rat brainstem. | Mol Biol Rep | 2022 | 34797492 | PubTator, text mining | PubMed |
| Design Strategies, Chemistry and Therapeutic Insights of Multi-target Directed Ligands as Antidepressant Agents. | Curr Neuropharmacol | 2022 | 34727859 | PubTator, text mining | PubMed |
| Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases. | Eur J Med Chem | 2022 | 34710746 | PubTator, text mining | PubMed |
| Cardiovascular serotonergic system: Evolution, receptors, transporter, and function. | J Exp Zool A Ecol Integr Physiol | 2022 | 34662506 | PubTator, text mining | PubMed |
| Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy. | Cell Mol Immunol | 2022 | 34417572 | PubTator, text mining | PubMed |
| Treatment-resistant bipolar depression: concepts and challenges for novel interventions. | Braz J Psychiatry | 2022 | 34037084 | PubTator, text mining | PubMed |
| Update on GPCR-based targets for the development of novel antidepressants. | Mol Psychiatry | 2022 | 33589739 | PubTator, text mining | PubMed |
| Searching for new drugs for the treatment of dementia-related psychosis. | Postep Psychiatr Neurol | 2021 | 37082556 | PubTator, text mining | PubMed |
| Monoaminergic and Opioidergic Modulation of Brainstem Circuits: New Insights Into the Clinical Challenges of Pain Treatment? | Front Pain Res (Lausanne) | 2021 | 35295506 | PubTator, text mining | PubMed |
Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D3 Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders. | Front Psychiatry | 2021 | 35095615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3363/papers?page=18